Navigation Links
Genomics Firm Nabsys Completes Financial Restructuring and Reinstates Technical Leadership Team
Date:3/31/2016

PROVIDENCE, R.I., March 31, 2016 /PRNewswire/ -- Genomics firm Nabsys has completed a financial  restructuring under the leadership of founding CEO, Barrett Bready, M.D., who returned to the company in October 2015. In addition, members of the original technical leadership team, including Chief Technology Officer, John Oliver, Ph.D., Executive Vice President of Product Development, Steve Nurnberg and Vice President of Software and Informatics, Michael Kaiser have returned to the company.

Dr. Bready served as CEO of Nabsys from 2005-2014 and raised $50 million to develop the company's high definition electronic DNA mapping platform. In early 2015, under different leadership, the company pivoted to a different and ultimately unsuccessful technical approach. Dr. Bready returned to Nabsys in October 2015, recruited back the technical leadership team and has re-focused the company on its core technology.

Nabsys has developed semiconductor-based nanodetectors to analyze very long DNA molecules electronically, at high velocity and with much greater resolution than offered by optical approaches. This technology allows researchers, and will ultimately allow clinicians, to draw conclusions about DNA that would be difficult or impossible with other technologies. 

"I'm grateful that all members of our technical leadership team have returned to Nabsys in recent months," said Bready. "The fact that we were able to get the team organized so quickly meant that very little time was lost during this transition period. The past six months have been the most productive in the company's history."

John Oliver, Ph.D., added, "The Nabsys platform is incredibly powerful when applied to the right challenges and has an unprecedented ability to scale. We are excited to once again be exploring the potential of this technology as a team and anticipate sharing our progress in the near future."

About Nabsys
Nabsys develops semiconductor-based tools for genomic analysis. The company has pioneered the technology of electronic mapping which is capable of analyzing entire genomes, in very large fragments (100,000 bp and higher) traveling at high velocity (greater than 1 million base pairs per second). Nabsys was the first company to receive a "1000 Genome" award from the National Human Genome Research Institute of the National Institutes of Health for an electronic approach to DNA analysis.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/genomics-firm-nabsys-completes-financial-restructuring-and-reinstates-technical-leadership-team-300243783.html


'/>"/>
SOURCE Nabsys
Copyright©2016 PR Newswire.
All rights reserved


Related biology news :

1. Newborn Screening Ontario Inks Deal with Tute Genomics, UNIConnect Team to Deliver Informatics Infrastructure for NGS Testing
2. Rubicon Genomics Announces Eurofins Scientific Will Distribute Its Suite of DNA Library Preparation Kits in U.S.
3. Den 10. internationale konference om Genomics (ICG-10) åbner i oktober
4. La 10e International Conference on Genomics (ICG-10) doit souvrir en octobre
5. La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre
6. The 10th International Conference on Genomics (ICG-10) to Open in October
7. American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect
8. ACT Genomics Raises $8 Million in its First Private Funding Round
9. Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine
10. The Genome Institute at Washington University Receives Irys System from BioNano Genomics to Advance Research for Genome Reference Consortium
11. Genomics Market by Products - [Instruments (NGS platform, Microarray, RT-PCR), Consumables (Genechips, Reagents for DNA Extraction & Purification, Sequencing)], Services (Sequencing & Microarray Services, and Software) - Global Forecast to 2018
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2019)... ... February 27, 2019 , ... Fluxion Biosciences, a leading developer of precision ... National Cancer Institute grant for further development of its ERASE-Seq liquid biopsy technology. The ... the lab of Dr. Omar Mian at the Cleveland Clinic. , Liquid biopsies offer ...
(Date:2/22/2019)... Wisc. (PRWEB) , ... February 21, 2019 , ... Clean ... is now expected when creating natural foods and beverages. It is quite common to ... fine print. Yet, meat products are not immune to this label scrutiny. , ...
(Date:2/19/2019)... ... February 19, 2019 , ... ... Mark Hozza as Chief Commercial Officer of the life science research and advisory ... performance, strategy, and alignment of all market research and media revenue operations in ...
Breaking Biology News(10 mins):
(Date:3/9/2019)... ... March 07, 2019 , ... ACEA ... the development and commercialization of high performance, cutting-edge cell analysis platforms for life ... with GLP-certified expertise in cardiovascular pharmacology and electrophysiology, are announcing a partnership to ...
(Date:3/4/2019)... ... ... hot topics through free webinars presented by leading experts in pharma, biotech, medical device and ... save your place! Participate in the discussion and stay relevant in your field! , Visit ... March 20 – Implementing BYOD Across Phase II and III Clinical Trials , ...
(Date:2/22/2019)... ... February 20, 2019 , ... ... , an emerging leader in the rapidly growing NGS (Next Generation Sequencing) field, ... Murrieta Genomics laboratory and incubator. , "As an innovation center and idea incubator, ...
(Date:2/16/2019)... , ... February 14, 2019 , ... ... analytics, and knowledge sharing capability that also provides the flexibility for users to ... functionality. It also provides a shared workbench to conduct quick analytics on near-real-time ...
Breaking Biology Technology: